International Andrology, a London-based men's health clinic, has experienced a surge in men enquiring about erectile dysfunction (ED) treatments and drugs in the lead up to Valentine's Day.

Over the past two weeks the clinic has seen a 300% increase in ED-related enquiries. This prompted the clinic to run an internal survey with the men that contacted them, regarding their Valentine's Day plans and whether they were planning to use ED medication for the occasion.

The results of the survey reveal that over 80% of men who were planning to celebrate Valentine's day, purchased ED drugs specifically for that occasion to make sure they are able to perform on the day - irrespective of whether they identified themselves as suffering from ED or not.

The survey results are summarised below:

• Out of the 250 men surveyed, 54% were planning to celebrate Valentine's day with their partners;
• Out of the 135 men with Valentine's day plans, 104 (77%) of them were planning to take ED medications specifically for the occasion;
• 34% of the men enquiring about ED drugs, said that they do not think they suffer from ED but were planning to take them so as to impress their partners on the day.

Christos Konstantinidis, director of the clinic, commented: "It is not surprising to see that men feel pressured to perform sexually on Valentine's Day. Although this is understandable for men suffering from ED, the surprising fact of our survey is that a lot of these men (34% of the respondents) actually do not identify themselves as suffering from erection issues but want this extra boost that ED drugs give in order to impress their partners.

"Recreational use of ED medication is not something that should be encouraged but with online pharmacies providing access to these drugs with minimal medical checks, it is imperative that men are aware about the safe use of ED medication."

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.